Abstract:Background: Increasing evidence from observational studies and clinical experimentation has indicated a link between the gut microbiotas (GMs) and polycystic ovary syndrome (PCOS), however, the causality and direction of causality between gut microbiome and PCOS remains to be established. Methods: We conducted a comprehensive search of four databases-PubMed, Cochrane Library, Web of Science, and Embase up until June 1, 2023, and subjected the results to a meta-analysis. In this study, a bidirectional two-sample Mendelian randomization (MR) analysis was employed to investigate the impact of gut microbiota on polycystic ovary syndrome (PCOS). The genome-wide association study (GWAS) data for PCOS comprised 113,238 samples, while the GWAS data for gut microbiota were derived from the MiBioGen consortium, encompassing a total sample size of 18,340 individuals. As the largest dataset of its kind, this study represents the most comprehensive genome-wide meta-analysis concerning gut microbiota composition to date. Single nucleotide polymorphisms (SNPs) were selected as instrumental variables at various taxonomic levels, including Phylum, Class, Order, Family, and Genus. The causal associations between exposures and outcomes were assessed using four established MR methods. To correct for multiple testing, the false discovery rate (FDR) method was applied. The reliability and potential biases of the results were evaluated through sensitivity analysis and F-statistics. Results: The meta-analysis incorporated a total of 20 studies that met the criteria, revealing a close association between PCOS and specific gut microbiota species. As per the results from our MR analysis, we identified six causal associations between the gut microbiome and polycystic ovary syndrome (PCOS). At the genus level, Actinomyces (ORIVW = 1.369, FDR = 0.040), Streptococcus (ORIVW = 1.548, FDR = 0.027), and Ruminococcaceae UCG-005 (ORIVW = 1.488, FDR = 0.028) were identified as risk factors for PCOS. Conversely, Candidatus Soleaferrea (ORIVW = 0.723, FDR = 0.040), Dorea (ORIVW = 0.580, FDR = 0.032), and Ruminococcaceae UCG-011 (ORIVW = 0.732, FDR = 0.030) were found to be protective factors against PCOS. Furthermore, the MR-PRESSO global test and MR-Egger regression indicated that our study results were not affected by horizontal pleiotropy (p > 0.05). Finally, the leave-one-out analysis corroborated the robustness of the MR findings. Conclusion: Both our meta-analysis and MR study indicates that there is a causal relationship between the gut microbiome and PCOS, which may contribute to providing novel insights for the development of new preventive and therapeutic strategies for PCOS.

Gut microbiome and reproductive endocrine diseases: a Mendelian randomization study

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Investigating the metabolomic pathways in female reproductive endocrine disorders: a Mendelian randomization study

Unraveling the relationship between gut microbiota and site-specific endometriosis: a Mendelian randomization analysis

Causal Link Between Gut Microbiota and Infertility: A Two-sample Bidirectional Mendelian Randomization Study

Causal relationships between gut microbiota and polycystic ovarian syndrome: A bidirectional Mendelian randomization study

Genetic Insights into Intestinal Microbiota and Risk of Infertility: A Mendelian Randomization Study

Causal effects of gut microbiome on endometriosis: a two-sample mendelian randomization study

A two-sample mendelian randomization analysis investigates associations between gut microbiota and infertility

Association between gut microbiota and menstrual disorders: a two-sample Mendelian randomization study

Male infertility risk and gut microbiota: a Mendelian randomization study

Gut microbiota and risk of polycystic ovary syndrome: Insights from Mendelian randomization

The association between gut microbiome and PCOS: evidence from meta-analysis and two-sample mendelian randomization

Causal relationship between gut microbiota and polycystic ovary syndrome: a literature review and Mendelian randomization study

Causal associations between gut microbiota and adverse pregnancy outcomes: A two-sample Mendelian randomization study

Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study

Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

Gut microbiota and polycystic ovary syndrome, focus on genetic associations: a bidirectional Mendelian randomization study

Causal relationships between gut microbrome and digestive system diseases: A two-sample Mendelian randomization study

Causal relationship between gut microbiota and gynecological tumor: a two-sample Mendelian randomization study

Association between gut microbiota and male infertility: a two-sample Mendelian randomization study